Organization Overview
Historical Acquisition Tree
Alternative names
hyaluronidase (human recombinant) (hylenex) (2005 NDA)
Key: Halozyme Therapeutics (5) Acquired (1)
Key: Halozyme Therapeutics (2) Acquired (1)
Key: Halozyme Therapeutics (16) Acquired (2)
atezolizumab (tecentriq) (3 trials)
C1 Esterase Inhibitor (Human) (Cinryze) (2 trials)
insulin glargine (toujeo) (3 trials)
insulin human (humulin) (5 trials)
Key: Halozyme Therapeutics (5) Acquired (1)
Adenocarcinoma (Phase 3)
Angioedema (Phase 2)
Angioedemas, Hereditary (Phase 2)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Breast Neoplasms (Phase 2)
Carcinoma, Ductal (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Pancreatic Ductal (Phase 3)
Cholangiocarcinoma (Phase 1)
Dehydration (Phase 4)
Dermatitis (Phase 2)
Dermatitis, Allergic Contact (Phase 2)
Dermatitis, Contact (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Emergencies (Phase 4)
Esophageal Neoplasms (Phase 2)
Hypercholesterolemia (Phase 1)
Lung Neoplasms (Phase 1)
Neoplasms (Phase 1)
Osteoporosis (Phase 1)
Pancreatic Neoplasms (Phase 2)
Stomach Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 2)